Skip to main content Skip to navigation

WMS Events Calendar

Please see this page for MB ChB events.

Monday, April 03, 2023

Select tags to filter on
Sun, Apr 02 Today Tue, Apr 04 Jump to any date

Search calendar

Enter a search term into the box below to search for all events matching those terms.

Start typing a search term to generate results.

How do I use this calendar?

You can click on an event to display further information about it.

The toolbar above the calendar has buttons to view different events. Use the left and right arrow icons to view events in the past and future. The button inbetween returns you to today's view. The button to the right of this shows a mini-calendar to let you quickly jump to any date.

The dropdown box on the right allows you to see a different view of the calendar, such as an agenda or a termly view.

If this calendar has tags, you can use the labelled checkboxes at the top of the page to select just the tags you wish to view, and then click "Show selected". The calendar will be redisplayed with just the events related to these tags, making it easier to find what you're looking for.

Export as iCalendar
THE FIRST CELL and the human costs of pursuing cancer to the last - Prof. Azra Raza

We are thrilled to announce that we will be joined by Prof. Azra Raza on Monday 3rd April 2-3.30pm UK time. This online seminar is being organised as a collaboration with the TIA Centre Seminar Series, Health GRP and Warwick Cancer Centre.

Speaker: Prof. Azra Raza

Affiliation: Columbia University Medical Center, New York, USA

Zoom link: opens in a new window


Title: THE FIRST CELL and the human costs of pursuing cancer to the last

Abstract: Cancer will strike 1 in 2 men and 1 in 3 women. Yet, we are failing spectacularly to improve outcome for the majority of patients. Our contention is that the real solution to the cancer problem is to diagnose cancer early, at the stage of The First Cell. The footprints of early cancers, the surrogate biomarkers, need to be identified so we can detect the first cell. The rapidly evolving technologies are doing much in this area but need to be expanded. We study a pre-leukemic condition called myelodysplastic syndrome (MDS) with the hope that we can detect the first leukemia cells as the disease transforms to acute myeloid leukemia (AML). Towards this end, we have collected blood and bone marrow samples on MDS and AML patients since 1984. Today, our Tissue Repository has more than 60,000 samples. We propose novel methods to identify surrogate markers that can identify the First Cell through studying the serial samples of patients who evolve from MDS to AML.